The sector has seen billions in merger and acquisition activity in recent years; a September 2024 analysis by Insight ...

Radiologists who evaluate CT scans have diagnostic challenges due to the complexity of underlying anatomy and the potential ...

A serendipitous find in the National Museum of Natural History’s collections yielded just the second known specimen of a ...

I was fortunate to have traveled America’s blue highways in the golden age of roadside attractions. The year I fell in love ...

President Donald Trump signed an executive order in February banning transgender athletes from participating in girls sports, ...

In the 1970s, archaeologists discovered a strange grave in western Belgium, dating back to 100 CE or so. Unlike the 76 other graves, it actually had a skeleton inside it. But 50 years la ...

In a quiet neighborhood of Vienna, beneath a football field slated for renovation, the dead began to speak. Construction ...

By mapping the subcellular architecture and protein interactions within cells, researchers can better understand how mutations contribute to pediatric cancers and other conditions.

Bayer today announced that the U.S. Food and Drug Administration (FDA) has granted full approval for VITRAKVI® (larotrectinib), a first-in-class TRK inhibitor for the treatment of adult and pediatric ...